PHARMSOFT Dr. B. Rodust GmbH has been integrated into the CERTANIA Group, enhancing the collaborative offering of pharmacovigilance solutions within the life sciences sector.

Target Information

PHARMSOFT Dr. B. Rodust GmbH, headquartered in Dortmund, Germany, is a prominent provider of pharmacovigilance software and services. With over 30 years of industry experience, PHARMSOFT specializes in supporting small and mid-sized pharmaceutical companies, particularly within the German-speaking markets. The company's validated pharmacovigilance database, saphëus®, facilitates legally compliant management of drug safety data, adhering to international standards such as E2B(R2/R3). Their modular service offerings encompass essential functions including case processing (ICSRs), literature monitoring, regulatory report preparation (e.g., PSURs, DSURs), and submissions to authorities.

PHARMSOFT has established a robust market presence, reinforced by strong partnerships with industry associations such as Pharma Deutschland and a loyal customer base. A significant portion of its revenue stems from recurring SaaS income, indicative of a scalable and forward-looking business model. The integration into the CERTANIA Group will further enhance PHARMSOFT’s capabilities, enabling it to provide comprehensive pharmacovigilance solutions to an even wider array of clients.

Industry Overview

The pharmacovigilance industry is critical to ensuring drug safety and efficacy, playing a central role in protecting patient health. In Germany, which boasts one of the most advanced healthcare systems in E